Skip to main content
OpenTrials

Clinical trial condition

Extensive Stage Small Cell Lung Cancer

Explore clinical trials studying Extensive Stage Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

34 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Extensive Stage Small Cell Lung Cancer trial results

Active, Not Recruiting

Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer

NCT04699838

Conditions
Extensive Stage Small Cell Lung Cancer
Locations
  • University of Illinois Medical Center Chicago, Illinois, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • University of Maryland Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment

NCT06502977

Conditions
Extensive Stage Small Cell Lung Cancer, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The Second Affiliated Hospital of Army Medical University, People's Liberation Army Chongqing, Chongqing Municipality, China
  • Army Special Medical Center of Peoples Liberation Army Chongqing, Chongqing Municipality, China
  • Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou, Fujian, China
View Trial Details
Active, Not Recruiting

First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

NCT05361395

Conditions
Bites and Stings, Chemically-Induced Disorders, Extensive Stage Small Cell Lung Cancer, +9 more
Locations
  • University of Southern California, Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Christiana Care Health Services Newark, Delaware, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View all 44 locations
View Trial Details
Active, Not Recruiting

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

NCT05468489

Conditions
Extensive Stage Small Cell Lung Cancer
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • City of Hope - Phoenix Goodyear, Arizona, United States
  • Arizona Clinical Research Center (ACRC) Tucson, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 67 locations
View Trial Details

Related conditions